GERN | GeronNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$0.93
$0.00 (0.00%)

Geron (GERN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $0.93 vs 50 $1.27 / 200 $1.42
Projection
No cross projected
Test
No active test
Last cross
Death cross 24 Sep 2026 ยท projected 28 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $0.89 vs 50 $1.39 / 200 $2.37
Projection
No cross projected
Test
No active test
Last cross
Death cross week of 25 Aug 2025 ยท projected 29 bars out

4-hour as of 3 Nov 13:30 ET

Price
below both $0.93 vs 50 $1.15 / 200 $1.34
Projection
No cross projected
Test
No active test
Last cross
Death cross 1 Oct 2026 ยท projected 29 bars out

Cross history

30
crosses on record since 2017
14 golden16 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Oct 2026Death4-hour29 bars outNot tested
24 Sep 2026Death flatdaily28 bars outNot tested
25 Aug 2026Golden moderatedaily9 bars out2 bar cross test
6 Aug 2026Golden4-hour3 bars out3 bar cross test
22 Jun 2026Death steepdaily28 bars out4 bar cross test

About GERN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$12.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.